---
title: "The Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2024"
id: e5033078-aa77-4d2e-9663-2a30165aaf2e
authority: uk
place: "United Kingdom"
applies_also_from: []
kind: regulation
in_force: true
publisher_url: https://www.legislation.gov.uk/uksi/2024/1361
attribution: "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
solon_url: https://solon.orangecat.ch/law/e5033078-aa77-4d2e-9663-2a30165aaf2e
language: en
in_force_from: 2025-01-15
date_basis: publisher
status: consolidated
source_url: https://www.legislation.gov.uk/uksi/2024/1361/data.xml
read_on: 2026-11-10
sha256: 08660d5923b5b811365ec863e75d24c9a5a5de987cf39ff935f2f93d34de700b
provisions: 3
---

# The Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2024

## Title and introductory text {#prelims}

2024 No. 1361
Dangerous Drugs
The Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2024
Made
18th December 2024
Coming into force
15th January 2025
At the Court at Buckingham Palace, the 18th day of December 2024
Present,
The King’s Most Excellent Majesty in Council
In accordance with section 2(5) of the Misuse of Drugs Act 1971, a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and approved by a resolution of each House of Parliament.
Accordingly, His Majesty, in exercise of the powers conferred on Him by section 2(2) of that Act, is pleased, by and with the advice of His Privy Council, to order, and it is hereby ordered, as follows:

## 1 Citation, commencement and extent {#article-1}

(1) This Order may be cited as the Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2024 and comes into force on the twenty-eighth day after the day on which it is made.
(2) This Order extends to England and Wales, Scotland and Northern Ireland.

## 2 Amendments to the Misuse of Drugs Act 1971 {#article-2}

(1) Schedule 2 to the Misuse of Drugs Act 1971 is amended as follows.
(2) In Part 1 (which specifies the drugs which are subject to control as Class A drugs) in paragraph 1(a)—
(a) after “Anileridine.” insert—
AP-237 (1-[4-([2E]-3-phenyl-2-propen-1-yl)-1-piperazinyl]-1-butanone) (bucinnazine).
AP-238 (1-[2,6-dimethyl-4-[2E]-3-phenyl-2-propen-1-yl]-1-piperazinyl-1-propanone).
Azaprocin (1-[3-[(E)-3-phenyl-2-propen-1-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]propan-1-one).
;
(b) after “Oxymorphone.” insert—
para-methyl-AP-237 (1-[4-[2E]-3-(4-methylphenyl)-2-propen-1-yl]-1-piperazinyl-1-butanone).
para-nitroazaprocin (1-[3-[(E)-3-(4-nitrophenyl)-2-propen-1-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl)propan-1-one).
;
(c) after “1-Methyl-4-phenylpiperdine-4-carboxylic acid.” insert—
2-Methyl-AP-237 (1-[2-methyl-4-[2E]-3-phenyl-2-propen-1-yl]-1-piperazinyl-1-butanone).
.
(3) In Part 1 after paragraph 1(e) insert—
(ea) any compound (not being a compound for the time being specified in sub-paragraph (a) above) with a maximum molecular mass of 500 atomic mass units and structurally derived from 2-(2-benzyl-benzimidazol-1-yl)ethanamine by modification in any of the following ways, that is to say—
(i) by substitution at the nitrogen of the ethanamine to any extent by alkyl substituents containing up to three carbon atoms or alkenyl substituents containing up to three carbon atoms or by inclusion of the nitrogen atom (and no other atoms of the side chain) in a cyclic structure;
(ii) by substitution in the phenyl ring of the benzyl system to any extent by alkyl or haloalkyl containing up to six carbon atoms, alkoxy or haloalkoxy containing up to five carbon atoms, acetyloxy, hydroxy, cyano, halogen, thioalkyl containing up to five carbon atoms or alkylsulphonyl containing up to five carbon atoms;
(iii) by substitution at the 5- or 6- positions of the benzimidazole system by nitro, acetyl, cyano, methoxy, trifluoromethyl, trifluoromethoxy or halogen substituents;
(iv) by substitution at the benzylic carbon by a methyl group;
(v) by replacement of the benzylic carbon by a nitrogen, oxygen or sulphur atom;
(vi) by substitution in the phenyl ring of the benzyl system by an ethoxy group linked back to the phenyl ring to form a dihydrobenzofuran structure;
(vii) by replacement of the phenyl ring of the benzyl system by methylenedioxyphenyl.
.
(4) In Part 2 (which specifies the drugs which are subject to control as Class B drugs) in the entry for Methoxyphenidine in paragraph 1(a), at the end (and before the full stop) insert “(1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine) (methoxphenidine)”.
(5) In Part 3 (which specifies the drugs which are subject to control as Class C drugs) in paragraph 1(a)—
(a) after “Aminorex.” insert—
Bentazepam (5-phenyl-1,3,6,7,8,9-hexahydro-2H-[1]benzothieno[2,3-e][1,4]diazepin-2-one).
;
(b) after “Benzphetamine.” insert—
Bretazenil (tert-butyl-8-bromo-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo[1,5-a]-pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylate).
;
(c) after “Cathinone.” insert—
4’-Chloro-deschloroalprazolam (6-(4-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine).
;
(d) after “Clobazam.” insert—
Clobromazolam (8-bromo-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine).
;
(e) after “Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine).” insert—
Cloniprazepam (5-(2-chlorophenyl)-1-(cyclopropylmethyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one).
;
(f) after “Delorazepam.” insert—
Desalkylgidazepam (7-bromo-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one).
Deschloroclotizolam (2-chloro-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine).
;
(g) after “Diethylpropion.” insert—
Difludiazepam (7-chloro-5-(2,6-difluorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one).
;
(h) after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine).” insert—
Flubrotizolam (2-bromo-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2f][1,2,4]triazolo[4,3a][1,4]diazepine).
Fluclotizolam (2-chloro-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine).
;
(i) after “Fludiazepam.” insert—
Fluetizolam (2-ethyl-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine).
;
(j) after “Fonazepam (5-(2-Fluorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one).” insert—
Gidazepam (7-bromo-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-1-acetic acid hydrazide).
;
(k) after “Mesocarb.” insert—
Methylclonazepam (5-(2-chlorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one).
;
(l) after “Remimazolam.” insert—
Rilmazafone (5-([(2-aminoacetyl)amino]methyl)-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide).
;
(m) after “Tetrazepam.” insert—
Thionordazepam (7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-thione).
;
(n) after “Triazolam.” insert—
Xylazine.
.